Spots Global Cancer Trial Database for Dabrafenib and/or Trametinib Rollover Study
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Dabrafenib and/or Trametinib Rollover Study
Official Title: Open Label, Multi-center Roll-over Study to Assess Long Term Safety in Patients Who Have Completed a Global Novartis or GSK Sponsored Dabrafenib and/or Trametinib Study
Study ID: NCT03340506
Study Description
Brief Summary: This study is to provide access for patients who are receiving treatment with dabrafenib and/or trametinib in a Novartis-sponsored Oncology Global Development, Global Medical Affairs or a former GSK-sponsored study who have fulfilled the requirements for the primary objective, and who are judged by the investigator as benefiting from continued treatment in the parent study as judged by the Investigator at the completion of the parent study.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Honor Health Research Institute, Scottsdale, Arizona, United States
National Institute Of Health, Bethesda, Maryland, United States
James Cancer Hospital and Solove Research Institute Ohio State, Columbus, Ohio, United States
Mary Crowley Cancer Research, Dallas, Texas, United States
Novartis Investigative Site, Buenos Aires, , Argentina
Novartis Investigative Site, Innsbruck, , Austria
Novartis Investigative Site, Beijing, , China
Novartis Investigative Site, Copenhagen, , Denmark
Novartis Investigative Site, Lyon, , France
Novartis Investigative Site, Nantes Cedex 1, , France
Novartis Investigative Site, Paris, , France
Novartis Investigative Site, Villejuif, , France
Novartis Investigative Site, Mannheim, Baden Wuerttemberg, Germany
Novartis Investigative Site, Berlin, , Germany
Novartis Investigative Site, Hamburg, , Germany
Novartis Investigative Site, Heidelberg, , Germany
Novartis Investigative Site, Budapest, , Hungary
Novartis Investigative Site, Debrecen, , Hungary
Novartis Investigative Site, Kashiwa, Chiba, Japan
Novartis Investigative Site, Chuo ku, Tokyo, Japan
Novartis Investigative Site, Rotterdam, , Netherlands
Novartis Investigative Site, Utrecht, , Netherlands
Novartis Investigative Site, Barcelona, Catalunya, Spain
Novartis Investigative Site, Madrid, , Spain
Novartis Investigative Site, Madrid, , Spain
Novartis Investigative Site, Madrid, , Spain
Novartis Investigative Site, Songkla, , Thailand
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
